We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NVRI:NYSEEnviri Corporation Analysis

Data as of 2026-06-01 - not real-time

$20.75

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Enviri (NVRI) is trading at $20.75, comfortably above its 20‑day SMA (19.62) and 50‑day SMA (19.39) while still below the 52‑week high of $21.42, indicating a bullish technical backdrop. The RSI of 63 points to modest overbought pressure, but the MACD remains bullish and volume is increasing, supporting short‑term upside toward the $21.42 resistance. Fundamentally, the company posted flat Q1 revenue (~$550 M) with a GAAP loss of $8 M yet delivered a non‑GAAP profit of $0.10 per share, suggesting a potential earnings turnaround. However, the balance sheet is strained – $1.73 B of debt versus $107 M cash (Debt/Equity > 600) and negative ROE – and the P/E is negative, while the price‑to‑book sits at 7.4×. The recent spin‑off of Clean Earth and Harsco segments (effective June 1 2026) could unlock value but also adds execution risk.
Overall, the stock appears fairly valued relative to its sales (P/S ≈ 0.77) but carries elevated financial and sector‑specific risks. Investors should weigh the upside from restructuring against the heavy debt load and ongoing profitability challenges.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish technical indicators (SMA crossover, MACD)
  • Proximity to resistance at $21.42 and elevated RSI
  • Upcoming corporate spin‑off creating short‑term volatility

Medium Term

1–3 years
Positive
Model confidence: 7/10

Key Factors

  • Potential earnings improvement from restructuring
  • Forward EPS improvement to -$0.385
  • Fair valuation relative to sales and modest upside to target ~ $21.5

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • High debt burden limiting financial flexibility
  • Environmental services tailwinds in waste management
  • Uncertain profitability trajectory despite operational cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth0.30%
Profit Margin-7.55%
P/E Ratio-53.9
ROE-44.61%
ROA0.04%
Debt/Equity628.11
P/B Ratio7.4
Op. Cash Flow$116.3M
Free Cash Flow$71.5M
Industry P/E29.9

Technical Analysis

TrendBullish
RSI63.2
Support$18.54
Resistance$21.42
MA 20$19.62
MA 50$19.39
MA 200$16.40
MACDBullish
VolumeIncreasing
Fear & Greed Index92.96

Valuation

Target Price$21.67
Upside/Downside4.42%
GradeFair
TypeValue

Risk Assessment

Beta1.03
Volatility27.94%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.